前沿生物-U
(688221)
| 流通市值：28.17亿 | | | 总市值：28.17亿 |
| 流通股本：3.75亿 | | | 总股本：3.75亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 73,999,086.35 | 374,806,392.46 | 181,954,943.44 | 526,663,249.91 |
| 应收票据及应收账款 | 43,617,532.84 | 41,221,062.46 | 47,501,196.32 | 63,008,781.14 |
| 应收账款 | 43,617,532.84 | 41,221,062.46 | 47,501,196.32 | 63,008,781.14 |
| 预付款项 | 33,648,101.66 | 30,173,139.4 | 24,113,465.06 | 23,479,570.17 |
| 其他应收款合计 | 5,896,063.02 | 5,794,203.66 | 6,313,021.75 | 2,370,670.36 |
| 存货 | 58,832,237.19 | 63,283,390.16 | 55,425,448.16 | 59,002,295.21 |
| 其他流动资产 | 214,984,015.5 | 64,404,254.55 | 13,119,405.54 | 13,203,675.84 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,019,445,815.4 | 1,063,499,271.46 | 1,045,696,663.75 | 1,102,785,645.43 |
| 非流动资产: | | | | |
| 固定资产 | 257,484,332.71 | 261,119,704.31 | 92,302,493.68 | 94,079,786.32 |
| 在建工程 | 534,588,012.63 | 531,754,209.23 | 705,288,548.58 | 695,969,059.79 |
| 使用权资产 | 1,040,447.72 | 1,506,410.54 | 1,987,386.36 | 2,969,157.24 |
| 无形资产 | 174,684,686.93 | 180,069,466.04 | 222,556,474.63 | 229,175,249.41 |
| 长期待摊费用 | 3,739,930.4 | 4,007,056.31 | 815,453.87 | 935,702.1 |
| 其他非流动资产 | 14,644,811.87 | 15,217,205.37 | 14,899,715.96 | 14,211,895.95 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 986,182,222.26 | 993,674,051.8 | 1,037,850,073.08 | 1,037,340,850.81 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,005,628,037.66 | 2,057,173,323.26 | 2,083,546,736.83 | 2,140,126,496.24 |
| 流动负债: | | | | |
| 短期借款 | 294,235,203.95 | 268,915,116.01 | 197,025,253.77 | 202,299,231.94 |
| 应付票据及应付账款 | 24,001,600.54 | 26,734,487.68 | 11,688,768.62 | 17,435,238.06 |
| 应付账款 | 24,001,600.54 | 26,734,487.68 | 11,688,768.62 | 17,435,238.06 |
| 合同负债 | 1,064,228.78 | 1,516,488.48 | 1,754,276.32 | 5,832,452.69 |
| 应付职工薪酬 | 19,605,456.37 | 16,247,787.49 | 14,005,176.4 | 19,634,852.68 |
| 应交税费 | 1,345,296.63 | 912,388.93 | 1,098,183.48 | 634,758.7 |
| 其他应付款合计 | 31,608,952.72 | 24,100,636.37 | 23,588,619.43 | 23,052,308.95 |
| 其中:应付利息 | 397,028.1 | 363,992.23 | 471,529.19 | 986,240.01 |
| 一年内到期的非流动负债 | 104,221,349.83 | 134,814,883.79 | 97,412,664.5 | 111,187,494.66 |
| 其他流动负债 | 140,494.71 | 213,516.66 | 222,186.23 | 81,834.18 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 476,222,583.53 | 473,455,305.41 | 346,795,128.75 | 380,158,171.86 |
| 非流动负债: | | | | |
| 长期借款 | 50,178,000 | 52,420,000 | 100,183,082.73 | 71,420,000 |
| 租赁负债 | - | - | - | 169,537.84 |
| 长期应付款 | 232,548,663.41 | 232,357,511.24 | 232,168,518.8 | 230,981,661.68 |
| 递延收益 | 97,464,375.26 | 116,713,429.31 | 117,423,883.36 | 114,715,037.41 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 380,191,038.67 | 401,490,940.55 | 449,775,484.89 | 417,286,236.93 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 856,413,622.2 | 874,946,245.96 | 796,570,613.64 | 797,444,408.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 374,578,653 | 374,578,653 | 374,578,653 | 374,578,653 |
| 资本公积 | 2,723,191,887.05 | 2,723,191,887.05 | 2,723,191,887.05 | 2,723,191,887.05 |
| 其他综合收益 | 921.27 | 14,907.09 | 11,052.81 | 10,839.09 |
| 未分配利润 | -1,948,557,045.86 | -1,915,558,369.84 | -1,810,805,469.67 | -1,755,099,291.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,149,214,415.46 | 1,182,227,077.3 | 1,286,976,123.19 | 1,342,682,087.45 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,149,214,415.46 | 1,182,227,077.3 | 1,286,976,123.19 | 1,342,682,087.45 |
| 负债和股东权益合计 | 2,005,628,037.66 | 2,057,173,323.26 | 2,083,546,736.83 | 2,140,126,496.24 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-26 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |